GO:0035195 miRNA-mediated post-transcriptional gene silencing: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035195 describes how microRNAs (miRNAs) guide the RNA-induced silencing complex (RISC) to repress target gene expression after transcription.
• miRNAs are endogenous 21-24 nucleotide small RNAs processed from stem-loop precursors and loaded into Argonaute proteins.
• Silencing occurs by endonucleolytic cleavage of target RNA or by translational repression often coupled to poly-A tail shortening and mRNA degradation.
• Accessory RNA-binding proteins such as Sfpq, AUF1 and KHSRP modulate the efficiency and specificity of miRNA-mediated silencing.
• miRNA-mediated silencing is essential in development, pregnancy, epithelial-to-mesenchymal transition and viral vector production.
• CRISPR knockout, knock-in, point-mutation and overexpression models enable causal dissection of miRNA pathway components.
Description
miRNA-mediated post-transcriptional gene silencing (GO:0035195) is a biological process in which regulatory microRNAs (miRNAs) direct the repression of specific target genes after their transcripts have been produced. miRNAs are endogenous 21-24 nucleotide small RNAs generated from stem-loop RNA precursors (pre-miRNAs); once incorporated into a RNA-induced silencing complex (RISC), they downregulate protein production by endonucleolytic cleavage of the RNA or by translational repression, usually accompanied by poly-A tail shortening and subsequent degradation of the mRNA. This process is conserved in animals and plants and is distinct from siRNA-mediated silencing, which occurs in lower animals and plants. For researchers, GO:0035195 is a central node connecting RNA biology, gene regulation and disease. The pathway controls developmental timing, cell fate, immune responses and metabolic programs, and its dysregulation is linked to cancer, pregnancy disorders and viral vector yield. Because miRNAs fine-tune rather than abolish gene expression, experimental systems must resolve subtle changes in mRNA stability and translation, making CRISPR-based models and quantitative methods essential. Understanding the molecular players of GO:0035195, including Argonaute proteins, GW182, Sfpq, AUF1 and KHSRP, allows researchers to design targeted interventions and to interpret transcriptomic and proteomic data in the context of post-transcriptional control.
miRNA-mediated post-transcriptional gene silencing At A Glance
| GO ID | GO:0035195 |
|---|---|
| GO term | miRNA-mediated post-transcriptional gene silencing |
| Ontology | biological_process |
| Synonym | gene silencing by microRNA; gene silencing by miRNA; microRNA-mediated gene silencing; miRNA-mediated gene silencing |
| Major function | Downregulation of protein production from specific target genes via RISC-guided endonucleolytic cleavage or translational repression with mRNA destabilization |
| Small RNA class | Endogenous 21-24 nucleotide miRNAs processed from stem-loop pre-miRNAs |
| Core machinery | Argonaute-containing RISC and associated RNA-binding proteins such as Sfpq, AUF1 and KHSRP |
| Taxonomic distribution | miRNAs are present in all animals and in plants; siRNAs are present in lower animals and in plants |
| Key outcome | Reduced protein output, often accompanied by poly-A tail shortening and degradation of the target mRNA |
What Is GO:0035195?
GO:0035195 is the biological process in which microRNAs (miRNAs) cause post-transcriptional silencing of specific target genes. miRNAs are endogenous 21-24 nucleotide small RNAs processed from stem-loop precursors; after incorporation into RISC, they downregulate protein output either by endonucleolytic cleavage of the target RNA or by translational repression, often with poly-A tail shortening and mRNA degradation.
Why Is miRNA-mediated post-transcriptional gene silencing Important in Cell Biology?
GO:0035195 is important because it explains how cells use small RNAs to fine-tune gene expression after transcription, a layer of control that shapes development, differentiation, stress responses and disease. The pathway determines the steady-state levels of many mRNAs and proteins, and its perturbation alters phenotypes ranging from epithelial-to-mesenchymal transition to pregnancy outcomes and viral vector yield. Because miRNAs act catalytically through RISC, even modest changes in pathway components can have broad transcriptomic consequences, making this process a frequent target of functional genomics studies.
• Controls developmental timing and cell fate decisions by repressing specific target mRNAs.
• Regulates epithelial-to-mesenchymal transition through miRNA-mediated silencing of KHSRP and downstream programs.
• Contributes to pregnancy establishment and maintenance, with miRNAs implicated in trophoblast biology.
• Modulates viral vector production, as miRNA-mediated silencing of transgenes can increase adeno-associated viral vector yield and targeting specificity.
• Influences mRNA stability and translation efficiency, requiring integrated transcriptomic and proteomic analysis.
• Is modulated by nucleoplasmic RNA-binding proteins such as Sfpq, which control silencing efficiency.
• Involves AUF1, which facilitates miRNA-mediated gene silencing and links mRNA decay to RISC function.
• Connects to Argonaute-dependent ribosome-associated protein quality control, linking translation surveillance to small RNA pathways.
• Provides a mechanistic basis for interpreting non-coding variant effects in disease and for designing RNA-targeted therapeutics.
• Serves as a paradigm for post-transcriptional gene regulation that can be dissected with CRISPR knockout, knock-in and overexpression models.
What Happens During miRNA-mediated post-transcriptional gene silencing?
miRNA biogenesis and RISC loading
In simple terms: First, the cell makes a small RNA and loads it into a protein machine that will find target messages.
miRNAs are endogenous 21-24 nucleotide small RNAs processed from stem-loop RNA precursors (pre-miRNAs). Once incorporated into a RNA-induced silencing complex (RISC), the miRNA serves as a guide for target recognition. Argonaute proteins form the core of RISC and are central to downstream silencing steps. This loading step determines which transcripts will be regulated and is therefore a key control point in GO:0035195.
Target recognition and endonucleolytic cleavage
In simple terms: The loaded machine can cut a matching message like molecular scissors.
After RISC assembly, miRNAs can downregulate protein production by endonucleolytic cleavage of the RNA (often mRNA). This cleavage mechanism is one of the two principal post-transcriptional outcomes described for GO:0035195 and is particularly relevant when guide-target complementarity is extensive. Argonaute-dependent mechanisms also intersect with ribosome-associated protein quality control, linking target recognition to translation surveillance.
Translational repression and mRNA destabilization
In simple terms: Alternatively, the machine can slow protein production and trigger the message's tail to shorten and be degraded.
The second major outcome is mRNA translational repression, usually accompanied by poly-A tail shortening and subsequent degradation of the mRNA. This mode of silencing reduces protein output without necessarily eliminating the transcript immediately, and it requires coordination between RISC and mRNA decay machinery. AUF1 facilitates miRNA-mediated gene silencing, providing a direct link between mRNA stability factors and the silencing pathway.
Regulation by nucleoplasmic and RNA-binding proteins
In simple terms: Other proteins in the nucleus and cytoplasm can tune how strongly the silencing machine works.
Post-transcriptional gene silencing mediated by microRNAs is controlled by nucleoplasmic Sfpq, which modulates the efficiency of the process. KHSRP is itself subject to miRNA-mediated silencing and rewires distinct post-transcriptional programs during TGF-beta-induced epithelial-to-mesenchymal transition. Together with AUF1, these factors illustrate that GO:0035195 is not a fixed linear pathway but a regulated network responsive to cellular context.
Physiological and applied contexts
In simple terms: This process matters in real biology, from pregnancy to making viral vectors.
miRNAs are implicated in pregnancy, where they contribute to reproductive biology and trophoblast function. In biotechnology, miRNA-mediated post-transcriptional silencing of transgenes leads to increased adeno-associated viral vector yield and targeting specificity. These examples show that GO:0035195 operates across physiology and applied gene therapy.
Key Genes Involved in GO:0035195 miRNA-mediated post-transcriptional gene silencing
The following genes and proteins are experimentally implicated in miRNA-mediated post-transcriptional gene silencing (GO:0035195) according to the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AGO2 | Core Argonaute protein of RISC that binds miRNAs and mediates silencing | Central effector for knockout and rescue studies of GO:0035195 |
| AGO1 | Argonaute family member contributing to RISC function and small RNA binding | Comparative knockout models to dissect Argonaute redundancy |
| SFPQ | Nucleoplasmic protein that controls miRNA-mediated post-transcriptional gene silencing | Knockdown or knockout to test silencing efficiency |
| AUF1 | RNA-binding protein that facilitates miRNA-mediated gene silencing | Target for testing mRNA stability coupling to RISC |
| KHSRP | RNA-binding protein silenced by miRNAs and rewiring post-transcriptional programs in EMT | Knockout or overexpression in TGF-beta EMT models |
| DICER1 | RNase III enzyme required for processing pre-miRNAs into mature miRNAs | Essential for miRNA biogenesis in pathway perturbation studies |
| DROSHA | Nuclear RNase III involved in primary miRNA processing | Knockout to block miRNA maturation and assess downstream effects |
| XPO5 | Exportin that transports pre-miRNAs to the cytoplasm | Loss-of-function models to separate nuclear and cytoplasmic steps |
| TNRC6A | GW182 family scaffold that bridges RISC to decay and repression machinery | Knockdown to uncouple RISC binding from silencing output |
| TNRC6B | GW182 family member involved in translational repression and mRNA deadenylation | Domain mapping and knockout for mechanistic studies |
| TNRC6C | GW182 family member contributing to miRNA-mediated repression | Redundancy studies with TNRC6A/B |
| PABPC1 | Poly(A)-binding protein linked to poly-A tail shortening and mRNA degradation | Interrogation of deadenylation-dependent silencing |
| CNOT1 | CCR4-NOT deadenylase complex subunit involved in miRNA-mediated mRNA decay | Knockout to test deadenylation requirement |
| EIF4E | Translation initiation factor whose activity is modulated during translational repression | Reporter assays to measure translation versus decay |
| MOV10 | RNA helicase associated with RISC and mRNA silencing | Overexpression and knockout to probe RISC dynamics |
| GEMIN5 | Assembly factor for small RNA-protein complexes | Loss-of-function to assess RISC loading defects |
| LIN28A | RNA-binding protein that regulates let-7 miRNA processing | Model for developmental control of miRNA biogenesis |
| MYC | Transcription factor whose output is influenced by miRNA-mediated silencing programs | Readout gene in EMT and proliferation studies |
How Is miRNA-mediated post-transcriptional gene silencing Regulated?
GO:0035195 is regulated at multiple levels. Nucleoplasmic Sfpq controls miRNA-mediated post-transcriptional gene silencing, indicating that subcellular localization and protein interactions tune silencing efficiency. AUF1 facilitates miRNA-mediated gene silencing, linking mRNA decay factors to RISC activity. KHSRP is itself a miRNA target and its silencing rewires post-transcriptional programs during TGF-beta-induced epithelial-to-mesenchymal transition, showing that the pathway is embedded in feedback and feedforward loops. Argonaute-dependent ribosome-associated protein quality control further connects silencing to translation surveillance and stress responses. Collectively, these mechanisms allow cells to adjust miRNA activity according to developmental and environmental cues.
miRNA-mediated post-transcriptional gene silencing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KHSRP | TGF-beta-induced epithelial-to-mesenchymal transition and cancer progression | Knockout and overexpression in epithelial cell lines with TGF-beta treatment |
| SFPQ | Post-transcriptional silencing control relevant to gene regulation | Knockdown or knockout with silencing reporter assays |
| AUF1 | mRNA stability and miRNA-mediated silencing | Knockout cells with mRNA decay and reporter measurements |
| AGO2 | Core RISC effector linked to translation surveillance | Point-mutation and knockout models for RISC function |
| DICER1 | miRNA biogenesis required for silencing | Conditional knockout to block miRNA maturation |
Cancer and epithelial-to-mesenchymal transition
miRNA-mediated silencing of KHSRP rewires distinct post-transcriptional programs during TGF-beta-induced epithelial-to-mesenchymal transition, a process central to cancer invasion and metastasis. Because GO:0035195 controls mRNA stability and translation, its perturbation can shift oncogenic programs without altering transcription. This makes pathway components attractive candidates for functional validation in cancer models.
Reproductive biology and pregnancy disorders
MicroRNAs are implicated in pregnancy, where they contribute to trophoblast function and maternal-fetal communication. Dysregulated miRNA-mediated silencing may therefore contribute to pregnancy complications, although specific mechanisms require further study. Experimental models of trophoblast cells can be used to test causal roles of individual miRNAs and RISC components.
Gene therapy and viral vector manufacturing
miRNA-mediated post-transcriptional silencing of transgenes leads to increased adeno-associated viral vector yield and targeting specificity, directly linking GO:0035195 to bioprocess engineering. This application shows that manipulating miRNA target sites can improve vector production and restrict expression to desired cell types. It also highlights the need for precise models to quantify silencing effects.
Neurological and translational stress contexts
Argonaute-dependent ribosome-associated protein quality control connects miRNA pathway components to translation surveillance, a process relevant to proteostasis and stress-related disease. Although direct disease links require further evidence, this intersection suggests that GO:0035195 may modulate cellular responses to misfolded proteins. Researchers can use reporter systems and ribosome profiling to test these hypotheses.
From miRNA-mediated post-transcriptional gene silencing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for miRNA-mediated silencing? | CRISPR knockout cell line with miRNA reporter |
| Does a specific residue in AGO2 affect guide loading or cleavage? | Point-mutation knock-in of AGO2 |
| Does a disease-associated variant alter silencing efficiency? | Knock-in of the variant with allelic reporter assays |
| Where and when is a pathway protein expressed? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of a miRNA or pathway factor enhance silencing? | Stable overexpression cell model |
| Can silencing of a transgene improve vector yield? | Overexpression and target-site engineering in producer cells |
How to Study the miRNA-mediated post-transcriptional gene silencing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Dual-luciferase reporter assay | Translational repression and target site activity | Testing miRNA response elements in knockout or overexpression cells |
| RNA-seq | Changes in mRNA abundance and stability | Identifying transcriptome-wide effects of pathway perturbation |
| Ribosome profiling | Translation efficiency and ribosome occupancy | Distinguishing translational repression from mRNA decay |
| Proteomics | Protein output changes | Detecting silencing effects not visible at mRNA level |
| RNA immunoprecipitation | Physical association of RISC with target RNAs | Mapping direct targets of Argonaute proteins |
| Fluorescence microscopy | Subcellular localization of pathway components | Testing Sfpq and AUF1 localization effects |
| Poly-A tail length assay | Deadenylation status of target mRNAs | Mechanistic studies of mRNA destabilization |
| CRISPR knockout screening | Requirement of genes for silencing | Identifying novel modulators of GO:0035195 |
Reporter assays for silencing output
Reporter constructs carrying miRNA target sites are widely used to measure translational repression and mRNA destabilization. These assays can distinguish cleavage from translational repression when combined with mRNA stability measurements. They are typically applied in knockout or overexpression backgrounds to test causality.
Transcriptomic and proteomic profiling
RNA-seq and proteomics can quantify changes in mRNA levels and protein output associated with GO:0035195. Because miRNAs often cause modest mRNA changes with larger protein effects, integrating both layers is important. Such profiling is used to identify direct and indirect targets of a miRNA or pathway component.
Ribosome profiling and translation measurements
Ribosome profiling captures translation efficiency and can reveal translational repression without major mRNA loss. This method is particularly useful when distinguishing GO:0035195 mechanisms. It can be combined with Argonaute-dependent quality control readouts.
Imaging and biochemical interaction assays
Fluorescence imaging of tagged RISC components and biochemical pull-downs can localize and quantify pathway assemblies. These approaches help determine where silencing occurs and which cofactors are present. They are often paired with genetic perturbation to test function.
How CRISPR Can Be Used to Study GO:0035195 miRNA-mediated post-transcriptional gene silencing
Knockout
CRISPR knockout of core pathway genes such as AGO2, DICER1 or TNRC6 family members can abolish or reduce miRNA-mediated silencing, providing causal evidence for their requirement in GO:0035195. Knockout of modulators like SFPQ or AUF1 can reveal context-specific effects on silencing efficiency. These models are typically validated with reporter assays and RNA-seq.
Point Mutation
Point mutations in Argonaute domains or in miRNA seed-complementary regions can separate guide loading, target binding and catalytic cleavage activities. Such models are useful for dissecting the two post-transcriptional mechanisms described for GO:0035195. They also help test whether a specific residue is required for translational repression versus endonucleolytic cleavage.
Knock-in
Knock-in of epitope or fluorescent tags at endogenous loci enables tracking of RISC components and associated factors in live cells. Knock-in of disease-associated variants can test whether they alter silencing output. These models preserve endogenous regulatory context, which is important for quantitative studies of GO:0035195.
Overexpression
Overexpression of a miRNA or of pathway components can enhance silencing and is used to test sufficiency in GO:0035195. In biotechnology, overexpression and target-site engineering can improve adeno-associated viral vector yield and specificity. Overexpression models are also used to study KHSRP silencing during epithelial-to-mesenchymal transition.
How EDITGENE Supports miRNA-mediated post-transcriptional gene silencing Research
Researchers studying miRNA-mediated post-transcriptional gene silencing-related genes often need to determine whether a candidate gene is causally involved in silencing, whether a specific residue controls guide loading or cleavage, and how overexpression or loss of function reshapes transcriptomic and proteomic outputs. EDITGENE provides CRISPR-engineered cell models and screening services designed to answer these questions with reproducible, publication-ready data.
Contact EDITGENE today to design your custom CRISPR model for miRNA-mediated post-transcriptional gene silencing research.
Frequently Asked Questions About miRNA-mediated post-transcriptional gene silencing
What is miRNA-mediated post-transcriptional gene silencing?
It is the biological process GO:0035195 in which microRNAs guide RISC to repress target genes after transcription, either by endonucleolytic cleavage of the RNA or by translational repression often accompanied by poly-A tail shortening and mRNA degradation.
What genes are involved in miRNA-mediated post-transcriptional gene silencing?
Key genes include Argonaute proteins such as AGO2, DICER1, DROSHA, XPO5, TNRC6 family members, SFPQ, AUF1 and KHSRP, all implicated in RISC function, miRNA biogenesis or silencing modulation.
How does miRNA-mediated silencing differ from siRNA-mediated silencing?
miRNAs are present in all animals and in plants, whereas siRNAs are present in lower animals and in plants; both can act through RISC but differ in origin and taxonomic distribution.
What are the two main mechanisms of miRNA-mediated silencing?
The two main post-transcriptional mechanisms are endonucleolytic cleavage of the target RNA and mRNA translational repression, usually accompanied by poly-A tail shortening and subsequent degradation of the mRNA.
Which proteins control the efficiency of miRNA-mediated silencing?
Nucleoplasmic Sfpq controls miRNA-mediated post-transcriptional gene silencing, AUF1 facilitates it, and KHSRP is itself silenced by miRNAs during epithelial-to-mesenchymal transition.
Is miRNA-mediated silencing important in pregnancy?
Yes, microRNAs are implicated in pregnancy and reproductive biology, where they contribute to trophoblast function and maternal-fetal communication.
Can miRNA-mediated silencing affect viral vector production?
Yes, miRNA-mediated post-transcriptional silencing of transgenes leads to increased adeno-associated viral vector yield and targeting specificity.
What methods are used to study GO:0035195?
Common methods include dual-luciferase reporter assays, RNA-seq, ribosome profiling, proteomics, RNA immunoprecipitation, fluorescence microscopy and CRISPR knockout screening.
How can CRISPR help study miRNA-mediated gene silencing?
CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of pathway components, separation of cleavage versus repression mechanisms, and validation of disease-associated variants.
What is the role of Argonaute proteins in miRNA-mediated silencing?
Argonaute proteins form the core of RISC, bind miRNAs and mediate silencing, and are also linked to ribosome-associated protein quality control.
Conclusion
GO:0035195, miRNA-mediated post-transcriptional gene silencing, is a conserved biological process in which miRNAs guide RISC to repress target genes by endonucleolytic cleavage or translational repression with mRNA destabilization. Its regulation by Sfpq, AUF1 and KHSRP and its roles in epithelial-to-mesenchymal transition, pregnancy and viral vector production make it a high-value area for functional genomics. CRISPR-engineered cell models and integrated omics provide the tools needed to move from correlation to causality in this pathway.
References
- 1. Reid CA et al.. 2017. miRNA-mediated post-transcriptional silencing of transgenes leads to increased adeno-associated viral vector yield and targeting specificity.. Gene Ther 24(8):462-469 PMID: 28617420
- 2. Quévillon Huberdeau M et al.. 2019. A guide to microRNA-mediated gene silencing.. FEBS J 286(4):642-652 PMID: 30267606
- 3. Bottini S et al.. 2017. Post-transcriptional gene silencing mediated by microRNAs is controlled by nucleoplasmic Sfpq.. Nat Commun 8(1):1189 PMID: 29084942
- 4. Gao Y et al.. 2023. Argonaute-dependent ribosome-associated protein quality control.. Trends Cell Biol 33(3):260-272 PMID: 35981909
- 5. Min KW et al.. 2017. AUF1 facilitates microRNA-mediated gene silencing.. Nucleic Acids Res 45(10):6064-6073 PMID: 28334781
- 6. Puppo M et al.. 2016. miRNA-Mediated KHSRP Silencing Rewires Distinct Post-transcriptional Programs during TGF-β-Induced Epithelial-to-Mesenchymal Transition.. Cell Rep 16(4):967-978 PMID: 27396342
- 7. Dexheimer PJ et al.. 2020. MicroRNAs: From Mechanism to Organism.. Front Cell Dev Biol 8:409 PMID: 32582699
- 8. Morales Prieto DM et al.. 2011. MicroRNAs in pregnancy.. J Reprod Immunol 88(2):106-11 PMID: 21353310
